BioLife Solutions Inc (BLFS)vsIntuitive Surgical Inc (ISRG)
BLFS
BioLife Solutions Inc
$29.15
-3.67%
HEALTHCARE · Cap: $1.36B
ISRG
Intuitive Surgical Inc
$345.42
-14.15%
HEALTHCARE · Cap: $145.76B
Smart Verdict
WallStSmart Research — data-driven comparison
Intuitive Surgical Inc generates 10309% more annual revenue ($10.58B vs $101.66M). ISRG leads profitability with a 28.1% profit margin vs -2.9%. ISRG appears more attractively valued with a PEG of 2.17. ISRG earns a higher WallStSmart Score of 64/100 (C+).
BLFS
Avoid30
out of 100
Grade: F
ISRG
Buy64
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-9.0%
Fair Value
$20.42
Current Price
$29.15
$8.73 premium
Margin of Safety
+78.5%
Fair Value
$1873.35
Current Price
$345.42
$1527.93 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Revenue surging 24.7% year-over-year
Strong operational efficiency at 30.9%
Safe zone — low bankruptcy risk
Large-cap with strong market position
Keeps 28 of every $100 in revenue as profit
Revenue surging 23.0% year-over-year
Areas to Watch
Smaller company, higher risk/reward
Operating margin of 0.1%
Expensive relative to growth rate
ROE of -2.8% — below average capital efficiency
Expensive relative to growth rate
Premium valuation, high expectations priced in
Comparative Analysis Report
WallStSmart ResearchBull Case : BLFS
The strongest argument for BLFS centers on Debt/Equity, Altman Z-Score, Revenue Growth. Revenue growth of 24.7% demonstrates continued momentum.
Bull Case : ISRG
The strongest argument for ISRG centers on Operating Margin, Altman Z-Score, Market Cap. Profitability is solid with margins at 28.1% and operating margin at 30.9%. Revenue growth of 23.0% demonstrates continued momentum.
Bear Case : BLFS
The primary concerns for BLFS are Market Cap, Operating Margin, PEG Ratio.
Bear Case : ISRG
The primary concerns for ISRG are PEG Ratio, P/E Ratio. A P/E of 50.5x leaves little room for execution misses.
Key Dynamics to Monitor
BLFS carries more volatility with a beta of 1.94 — expect wider price swings.
BLFS is growing revenue faster at 24.7% — sustainability is the question.
ISRG generates stronger free cash flow (809M), providing more financial flexibility.
Monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
ISRG scores higher overall (64/100 vs 30/100), backed by strong 28.1% margins and 23.0% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
BioLife Solutions Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the gene and cell therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company is headquartered in Bothell, Washington.
Intuitive Surgical Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Intuitive Surgical, Inc. is an American corporation that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System.
Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?